ACUTE MYELOID LEUKEMIA
Treating Acute Myeloid Leukemia
Acute myelogenous leukemia (AML) is a cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. The word "acute" in acute myelogenous leukemia denotes the disease's rapid progression. It's called myelogenous leukemia because it affects a group of white blood cells called the myeloid cells, which normally develop into the various types of mature blood cells, such as red blood cells, white blood cells and platelets. There is more than one type of treatment, including: Chemotherapy, the use of anticancer drugs -- often two or three -- such as cytarabine, anthracycline drugs, 6-thioguanine, hydroxyurea, or prednisone. Radiation therapy, the use of high-energy radiation to kill cancer cells. A bone marrow transplant, which involves use of high doses of chemotherapy and possibly radiation, followed by a transplant of bone-forming stem cells.
Purpose of the study
Assessing the efficiency of a new treatment
Results to date
Research completed with insufficient results. A further research program is being envisaged